SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VGNX -- Variagenics, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (30)7/25/2001 7:48:51 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 269
 
And Venter said "blah, blah, blah and blah, blah, blah."

Celera joins several other biotech companies that are researching SNPs and genetic patterns known as haplotypes. They include Millennium Pharmaceuticals Inc. of Cambridge, Mass. and Genaissance Pharmaceuticals, based in New Haven, Conn.

Message 16124194

Celera finally has a business plan. They couldn't find their own, so they borrowed.